LSE - Delayed Quote USD
(0ADR.L)
244.92
-24.59
(-9.12%)
At close: March 14 at 1:34:29 PM GMT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 19 | 19 | 23 | 22 |
Avg. Estimate | 543.3M | 577.79M | 2.45B | 2.87B |
Low Estimate | 536.5M | 557.2M | 2.42B | 2.77B |
High Estimate | 551M | 594M | 2.49B | 2.98B |
Year Ago Sales | 441.7M | 488.5M | 2.07B | 2.45B |
Sales Growth (year/est) | 23.00% | 18.28% | 18.20% | 17.32% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
0ADR.L | -- | -- | -- | -- |
S&P 500 | 9.70% | 3.97% | 8.29% | 13.85% |
Upgrades & Downgrades
Maintains | Barclays: Equal-Weight to Equal-Weight | 4/30/2025 |
Downgrade | Wolfe Research: Outperform to Peer Perform | 4/29/2025 |
Initiated | RBC Capital: Outperform | 3/6/2025 |
Maintains | Citigroup: Buy to Buy | 2/21/2025 |
Reiterates | Raymond James: Outperform to Outperform | 2/21/2025 |
Maintains | Stifel: Hold to Hold | 2/21/2025 |